
ABOUT CASSS MEETINGS
CASSS meetings bring together industry, regulatory and academic professionals for critical discussions to solve technical and regulatory challenges in the field of biopharmaceutical development. CASSS symposia and fora provide venues for biopharmaceutical professionals to:
- Connect with a relevant global network
- Gain tangible knowledge for career advancement
- Learn best practices from prominent contributors in the industry
-
DC Discussion Group
February 22, 2023The DC Discussion Group is partnering once again with the Washington Chromatography Discussion Group for their first in-person event of 2023.
-
CMC Conversations in Latin America
March 29, 2023The Latin America Forum explores a number of critical topics focused on improving the quality in development and manufacturing of biopharmaceutical products.
-
Bioassays: Scientific Approaches & Regulatory Strategies
April 17 to 19, 2023Bioassays: Scientific Approaches and Regulatory Strategies is a premier bioassay symposium that presents a truly unique opportunity for attendees to interact with key industry thought leaders and discuss topics such as current perspectives, strategies and technologies used for bioassays.
-
Analytical Technologies Europe
May 9 to 12, 2023Analytical Technologies Europe: Symposium on Analytical Sciences and Regulatory Trends in the Biopharmaceutical Industry provides an active forum for the discussion of recent developments, regulatory considerations, and practical applications of analytical technologies in the biopharmaceutical industry.
-
CGTP Summit
June 26, 2023The CGTP Summit will bring together industry, regulatory, and academic professionals to discuss pertinent challenges in the cell and gene therapy field. This one-day meeting will have an open format with deep dive discussions.
-
Cell and Gene Therapy Products: Manufacturing, Quality and Regulatory Considerations
June 27 to 29, 2023The Cell and Gene Therapy Products (CGTP) symposium enables the exchange of scientific ideas and dialogue with regulators that form the basis of evolving regulatory practices in the development of these diverse and innovative products.
-
CMC Strategy Forum North America
July 17 to 18, 2023This 2-day CMC forum will review the many initiatives that make up the next frontier in CMC.
-
Symposium on the Practical Applications of Mass Spectrometry in the Biotechnology Industry
September 6 to 8, 2023The focus of this Symposium is the practical application of mass spectrometry (MS) in the biotechnology industry. Mass Spectrometry is a critical analytical technology used in the discovery, development, and commercialization of biopharmaceuticals.
-
CE in the Biotechnology & Pharmaceutical Industries
September 24 to 27, 2023The goal of the CE Pharm Symposium is to provide a forum for the discussion of recent developments in CE analysis of protein, nucleotide, and small molecule pharmaceuticals. The presentations and workshops will be devoted completely to practical concerns to strengthen the use of CE within the biotechnology and pharmaceutical industries.
-
CMC Strategy Forum Europe
October 16 to 18, 2023The Forum will follow the established model of the CMC Forum series with focus on topics and regulatory updates relevant for Europe.
-
CMC Strategy Forum Japan
December 4 to 5, 2023The Japan Forum will follow the established model of the CMC Forum series with focus on topics and regulatory updates relevant for Japan and Asia Pacific. The Forum strives to share information with the regulatory agencies to assist them in merging good scientific and regulatory practices.
-
CMC Strategy Forum North America
January 22, 2024The purpose of the CMC Strategy Forum is to provide a venue for biotechnology/biological product discussion on relevant CMC issues throughout the lifecycle of a product.
-
WCBP
January 23 to 25, 2024It is with great pleasure that the WCBP Scientific Organizing Committee invites you to WCBP 2024.
Fast Facts
- Annually, CASSS holds 13 scientific, multi-day symposia and fora around the world.
- Attendees represent more than 30 regulatory agencies and over 100 biopharmaceutical companies from Africa, Asia, Australia, Canada, Europe, Latin America, Middle East, and United States.